Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Gastrointest Endosc. 2009 May 24;70(1):96–10924. doi: 10.1016/j.gie.2008.08.040

APPENDIX 3A. total population (uniform).

Efficient screening policies characterized by age range, screening interval and number of scheduled examinations and expressed as the 3% discounted life-time costs and life-expectancy of the policy.

Policy Resources and benefits

No. of scheduled exams Interval between exams (years) Age range Costs ($)*, Life-expectancy at age 40*
1 n.a. 70-70 1,701 22.4063
1 n.a. 65-65 1,720 22.4120
1 n.a. 64-64 1,725 22.4131
1 n.a. 63-63 1,731 22.4142
1 n.a. 62-62 1,737 22.4151
1 n.a. 61-61 1,747 22.4158
2 14 60-74 1,827 22.4213
2 14 59-73 1,845 22.4223
2 14 58-72 1,866 22.4233
3 9 57-75 2,010 22.4282
3 10 53-73 2,125 22.4315
3 9 53-71 2,151 22.4322
4 8 52-76 2,301 22.4353
4 8 51-75 2,349 22.4362
5 6 51-75 2,563 22.4390
5 7 47-75 2,733 22.4407
6 6 47-77 2,923 22.4426
7 5 48-78 3,077 22.4436
7 5 47-77 3,170 22.4441
8 5 47-82 3,223 22.4443
8 5 46-81 3,329 22.4448
8 5 43-78 3,659 22.4462
9 5 43-83 3,707 22.4464
10 5 43-88 3,732 22.4465
10 5 42-87 3,860 22.4466
*

Average of results for population subgroups, weighted by size of population subgroup

Lifetime per person cost for CRC screening and treatment after age 40